Kren B, Henzler C, Ahmed K, Trembley J
Mol Med. 2024; 30(1):175.
PMID: 39394061
PMC: 11476306.
DOI: 10.1186/s10020-024-00937-1.
Zhang G, Zheng C, Ding Y, Mello C
Nat Commun. 2024; 15(1):2727.
PMID: 38548791
PMC: 10978872.
DOI: 10.1038/s41467-024-46882-9.
Park A, Leney-Greene M, Lynberg M, Gabrielski J, Xu X, Schwarz B
Nat Immunol. 2024; 25(2):282-293.
PMID: 38172257
PMC: 11151279.
DOI: 10.1038/s41590-023-01691-y.
Ijaz S, Ul Haq I, Razzaq H, Nasir B, Ali H, Kaur S
Front Plant Sci. 2023; 14:1134806.
PMID: 37908834
PMC: 10613980.
DOI: 10.3389/fpls.2023.1134806.
Mitrovsky O, Myslivcova D, Machackova-Lopotova T, Obr A, cermakova K, Ransdorfova S
PLoS One. 2023; 18(5):e0284876.
PMID: 37141212
PMC: 10159124.
DOI: 10.1371/journal.pone.0284876.
Discovery of a Potent and Selective Naphthyridine-Based Chemical Probe for Casein Kinase 2.
Davis-Gilbert Z, Kramer A, Dunford J, Howell S, Senbabaoglu F, Wells C
ACS Med Chem Lett. 2023; 14(4):432-441.
PMID: 37077385
PMC: 10108397.
DOI: 10.1021/acsmedchemlett.2c00530.
Minor Kinases with Major Roles in Cytokinesis Regulation.
Sechi S, Piergentili R, Giansanti M
Cells. 2022; 11(22).
PMID: 36429067
PMC: 9688779.
DOI: 10.3390/cells11223639.
Antitumor activity of the protein kinase inhibitor 1-(β-D-2'-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell lines.
Koronkiewicz M, Kazimierczuk Z, Orzeszko A
BMC Cancer. 2022; 22(1):1069.
PMID: 36243702
PMC: 9571492.
DOI: 10.1186/s12885-022-10156-8.
CK2β Is a Gatekeeper of Focal Adhesions Regulating Cell Spreading.
Filhol O, Hesse A, Bouin A, Albiges-Rizo C, Jeanneret F, Battail C
Front Mol Biosci. 2022; 9:900947.
PMID: 35847979
PMC: 9280835.
DOI: 10.3389/fmolb.2022.900947.
Essential role of CK2α for the interaction and stability of replication fork factors during DNA synthesis and activation of the S-phase checkpoint.
Guerra B, Doktor T, Frederiksen S, Somyajit K, Andresen B
Cell Mol Life Sci. 2022; 79(6):339.
PMID: 35661926
PMC: 9166893.
DOI: 10.1007/s00018-022-04374-3.
variants of cause a new intellectual disability-craniodigital syndrome by disrupting the canonical Wnt signaling pathway.
Asif M, Kaygusuz E, Shinawi M, Nickelsen A, Hsieh T, Wagle P
HGG Adv. 2022; 3(3):100111.
PMID: 35571680
PMC: 9092267.
DOI: 10.1016/j.xhgg.2022.100111.
Bioactive phytoconstituents as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19 therapeutics.
Anjum F, Sulaimani M, Shafie A, Mohammad T, Ashraf G, Bilgrami A
RSC Adv. 2022; 12(13):7872-7882.
PMID: 35424745
PMC: 8982221.
DOI: 10.1039/d1ra09339h.
Inhibition of Protein Kinase CK2 Affects Thymidylate Synthesis Cycle Enzyme Level and Distribution in Human Cancer Cells.
Winska P, Widlo L, Senkara E, Koronkiewicz M, Ciesla J, Krzysko A
Front Mol Biosci. 2022; 9:847829.
PMID: 35281258
PMC: 8914513.
DOI: 10.3389/fmolb.2022.847829.
Regulation of sclerostin by the SIRT1 stabilization pathway in osteocytes.
Kim J, Yang Y, Xie J, Lee O, Kim J, Hong J
Cell Death Differ. 2022; 29(8):1625-1638.
PMID: 35169297
PMC: 9345882.
DOI: 10.1038/s41418-022-00952-x.
Synthesis of Novel Acyl Derivatives of 3-(4,5,6,7-Tetrabromo-1-benzimidazol-1-yl)propan-1-ols-Intracellular TBBi-Based CK2 Inhibitors with Proapoptotic Properties.
Chojnacki K, Winska P, Karatsai O, Koronkiewicz M, Milner-Krawczyk M, Wielechowska M
Int J Mol Sci. 2021; 22(12).
PMID: 34200807
PMC: 8230474.
DOI: 10.3390/ijms22126261.
Broad-Spectrum Anticancer Activity and Pharmacokinetic Properties of a Prenyloxy-Substituted Indeno[1,2-]indole Derivative, Discovered as CK2 Inhibitor.
El-Awaad E, Birus R, Marminon C, Bouaziz Z, Ballentin L, Aichele D
Pharmaceuticals (Basel). 2021; 14(6).
PMID: 34198928
PMC: 8226678.
DOI: 10.3390/ph14060542.
CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(-) HNSCC Cell Lines.
Trembley J, Li B, Kren B, Gravely A, Caicedo-Granados E, Klein M
Biomedicines. 2021; 9(5).
PMID: 34070147
PMC: 8158385.
DOI: 10.3390/biomedicines9050571.
Halogen Atoms in the Protein-Ligand System. Structural and Thermodynamic Studies of the Binding of Bromobenzotriazoles by the Catalytic Subunit of Human Protein Kinase CK2.
Czapinska H, Winiewska-Szajewska M, Szymaniec-Rutkowska A, Piasecka A, Bochtler M, Poznanski J
J Phys Chem B. 2021; 125(10):2491-2503.
PMID: 33689348
PMC: 8041304.
DOI: 10.1021/acs.jpcb.0c10264.
Development of a potent and selective chemical probe for the pleiotropic kinase CK2.
Wells C, Drewry D, Pickett J, Tjaden A, Kramer A, Muller S
Cell Chem Biol. 2021; 28(4):546-558.e10.
PMID: 33484635
PMC: 8864761.
DOI: 10.1016/j.chembiol.2020.12.013.
Evaluation of Combined CK2 Inhibition and Irradiation in Human WiDr Tumours.
Zwicker F, Hauswald H, Weber K, Debus J, Huber P
In Vivo. 2021; 35(1):111-117.
PMID: 33402456
PMC: 7880802.
DOI: 10.21873/invivo.12238.